Cargando…

DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells

Chronic myeloid leukemia is a hematological cancer driven by the oncoprotein BCR-ABL1, and lifelong treatment with tyrosine kinase inhibitors extends patient survival to nearly the life expectancy of the general population. Despite advances in the development of more potent tyrosine kinase inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Chun Shik, Lacorazza, H. Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080801/ https://www.ncbi.nlm.nih.gov/pubmed/33067577 http://dx.doi.org/10.1038/s12276-020-00515-5

Ejemplares similares

Sulforaphane Induces Cell Cycle Arrest and Apoptosis in Acute Lymphoblastic Leukemia Cells
por: Suppipat, Koramit, et al.
Publicado: (2012)

The Cytosolic Protein G0S2 Maintains Quiescence in Hematopoietic Stem Cells
por: Yamada, Takeshi, et al.
Publicado: (2012)

The transcription factor ELF4 controls proliferation and homing of CD8(+) T cells via the Krüppel-like factors KLF4 and KLF2
por: Yamada, Takeshi, et al.
Publicado: (2009)

Chronic myeloid leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019)

Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells
por: Lewis, Andrew Henry, et al.
Publicado: (2021)

Chronic Myeloid Leukemia Stem Cell Biology
por: Crews, Leslie A., et al.
Publicado: (2012)

Leukemia stem cells: the root of chronic myeloid leukemia
por: Zhou, Hong, et al.
Publicado: (2015)

Subtype-specific regulatory network rewiring in acute myeloid leukemia
por: Assi, Salam A., et al.
Publicado: (2018)

Stem Cell Biomarkers in Chronic Myeloid Leukemia
por: Jiang, Xiaoyan, et al.
Publicado: (2008)

Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
por: Hinterbrandner, Magdalena, et al.
Publicado: (2021)

Concise Review: Regulation of Self‐Renewal in Normal and Malignant Hematopoietic Stem Cells by Krüppel‐Like Factor 4
por: Park, Chun S., et al.
Publicado: (2019)

G0S2 modulates homeostatic proliferation of naïve CD8(+) T cells and inhibits oxidative phosphorylation in mitochondria
por: Lee, Ping-Hsien, et al.
Publicado: (2015)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

Selective inhibition reveals the regulatory function of DYRK2 in protein synthesis and calcium entry
por: Wei, Tiantian, et al.
Publicado: (2022)

Regulatory Networks of Prognostic mRNAs in Pediatric Acute Myeloid Leukemia
por: Zhang, Hao, et al.
Publicado: (2022)

Molecular signatures of chronic myeloid leukemia stem cells
por: Chen, Yaoyu, et al.
Publicado: (2013)

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
por: Adamo, Assunta, et al.
Publicado: (2022)

The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells
por: Khor, Bernard, et al.
Publicado: (2015)

Identification and functional characterization of the miRNA-gene regulatory network in chronic myeloid leukemia lineage negative cells
por: Agatheeswaran, S., et al.
Publicado: (2016)

The miR-203a Regulatory Network Affects the Proliferation of Chronic Myeloid Leukemia K562 Cells
por: He, Jinhua, et al.
Publicado: (2021)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia
por: Zhang, Haiguo, et al.
Publicado: (2017)

Retracted: Regulatory Networks of Prognostic mRNAs in Pediatric Acute Myeloid Leukemia
por: Healthcare Engineering, Journal of
Publicado: (2022)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
por: Houshmand, Mohammad, et al.
Publicado: (2021)

Chronic myeloid leukemia stem cells: targeting therapeutic implications
por: Mojtahedi, Hanieh, et al.
Publicado: (2021)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy
por: Li, Huayao, et al.
Publicado: (2018)

Chronic myeloid leukemia with extreme thrombocytosis
por: Kim, So Young, et al.
Publicado: (2012)

A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival
por: Lara-Chica, Maribel, et al.
Publicado: (2021)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia
por: Fujioka, Yuki, et al.
Publicado: (2021)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control
por: Singh, Rajeev, et al.
Publicado: (2017)

Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses
por: Láinez-González, Daniel, et al.
Publicado: (2023)

Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia
por: Tanturli, Michele, et al.
Publicado: (2011)

Current status of hematopoietic stem cell transplant in chronic myeloid leukemia
por: Gupta, Alok, et al.
Publicado: (2014)

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
por: Hamad, Ahmad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3fm78falk4kga9dumfn95k94op